Abbreviation	Full form
BC	Breast cancer
PDT	Photodynamic therapy
HYP	Hypericin
HYP-PDT	Hypericin-mediated photodynamic therapy
PS	Photosensitizer
1O2	Singlet oxygen
ROS	Reactive oxygen species
H2O2	Hydrogen peroxide
OH·	Hydroxyl radical
O2·−	Superoxide anion
MCF-7	Human breast adenocarcinoma cell line MCF-7
IL	Interleukin
IL-1	Interleukin 1
IL-2	Interleukin 2
IL-6	Interleukin 6
IL-8	Interleukin 8
IL-10	Interleukin 10
IL-11	Interleukin 11
IL-12	Interleukin 12
IL-17A	Interleukin 17A
IL-18	Interleukin 18
IL-19	Interleukin 19
IL-20	Interleukin 20
IL-22	Interleukin 22
IL-23	Interleukin 23
IFN-γ	Interferon gamma
TGF-β	Transforming growth factor beta
IRF-1	Interferon regulatory factor 1
IRF-2	Interferon regulatory factor 2
gp130 or GP130	Glycoprotein 130
MMP-1	Matrix metalloproteinase 1
TNF-α	Tumor necrosis factor alpha
DAMPs	Danger-associated molecular patterns
IC50	Half-maximal inhibitory concentration
ATCC	American Type Culture Collection
DMEM/F12	Dulbecco’s Modified Eagle’s Medium: F-12
EMEM	Eagle’s Minimum Essential Medium
FBS	Fetal bovine serum
EDTA	Ethylenediaminetetraacetic acid
PBS	Phosphate-buffered saline
DMSO	Dimethyl sulfoxide
IR	Infrared
CO2	Carbon dioxide
OD	Optical density
SD	Standard deviation
ANOVA	Analysis of variance
TNBC	Triple negative breast cancer
AuNPs	Gold nanoparticles
BCRP	Breast cancer resistance protein
MRP1	Multidrug resistance-associated protein 1
NFATc1	Nuclear factor of activated T cells c1
MAPK	Mitogen-activated protein kinase
PI3K	Phosphoinositide 3-kinase
STAT3	Signal transducer and activator of transcription 3
ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9
HPPH	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide a
SnEt2	Tin ethyl etiopurpurin
LuTex	Lutetium texaphyrin
ISO	International Organization for Standardization
CBD	Cannabidiol